BR112014027576A2 - soluções de oligoelementos e de traços de elementos e métodos de preparo de soluções e de suprimento de traços de elementos - Google Patents

soluções de oligoelementos e de traços de elementos e métodos de preparo de soluções e de suprimento de traços de elementos

Info

Publication number
BR112014027576A2
BR112014027576A2 BR112014027576A BR112014027576A BR112014027576A2 BR 112014027576 A2 BR112014027576 A2 BR 112014027576A2 BR 112014027576 A BR112014027576 A BR 112014027576A BR 112014027576 A BR112014027576 A BR 112014027576A BR 112014027576 A2 BR112014027576 A2 BR 112014027576A2
Authority
BR
Brazil
Prior art keywords
trace elements
solutions
methods
preparing
butaphosphane
Prior art date
Application number
BR112014027576A
Other languages
English (en)
Other versions
BR112014027576B1 (pt
Inventor
Alfred Smith William
Original Assignee
Warburton Technology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warburton Technology Ltd filed Critical Warburton Technology Ltd
Publication of BR112014027576A2 publication Critical patent/BR112014027576A2/pt
Publication of BR112014027576B1 publication Critical patent/BR112014027576B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/174—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/20—Inorganic substances, e.g. oligoelements
    • A23K20/30—Oligoelements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/10—Feeding-stuffs specially adapted for particular animals for ruminants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/18—Iodine; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/32—Manganese; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/34—Copper; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Inorganic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)

Abstract

“soluções de oligoelementos e de traços de elementos e métodos de preparo de soluções e de suprimento de traços de elementos” resumo a invenção revela uma solução de oligoelemento, que compreende pelo menos os seguintes metais: zinco, manganês, selênio e cobre; e que compreende vitamina b12. a solução ainda compreende butafosfano, para estabilizar a vitamina b12, e a inclusão de butafosfano por ter atividade sinérgica com os minerais. 1/1
BR112014027576-9A 2012-05-14 2012-05-14 soluções de oligoelementos BR112014027576B1 (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB2012/052389 WO2013171538A1 (en) 2012-05-14 2012-05-14 Trace element solution

Publications (2)

Publication Number Publication Date
BR112014027576A2 true BR112014027576A2 (pt) 2017-06-27
BR112014027576B1 BR112014027576B1 (pt) 2020-06-30

Family

ID=49583206

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112014027576-9A BR112014027576B1 (pt) 2012-05-14 2012-05-14 soluções de oligoelementos

Country Status (17)

Country Link
US (2) US20150320087A1 (pt)
EP (4) EP2849764B1 (pt)
AU (1) AU2012379964B2 (pt)
BR (1) BR112014027576B1 (pt)
CA (1) CA2871991C (pt)
DK (3) DK3915569T3 (pt)
ES (3) ES2953691T3 (pt)
FI (1) FI3915569T3 (pt)
HR (1) HRP20211302T1 (pt)
HU (2) HUE056783T2 (pt)
LT (2) LT3566708T (pt)
MX (1) MX360934B (pt)
PL (3) PL3566708T3 (pt)
PT (2) PT3915569T (pt)
SI (2) SI3915569T1 (pt)
WO (1) WO2013171538A1 (pt)
ZA (1) ZA201409093B (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3001104C (en) * 2015-10-09 2022-09-27 Warburton Technology Limited Trace element solution
KR102058133B1 (ko) 2019-02-22 2019-12-20 우진 비앤지 주식회사 혼합제제 내 항생제 용해도를 향상시킬 수 있는 면역 증강용 조성물 및 이의 용도
NZ785052A (en) 2019-07-12 2022-08-26 Chemvet Australia Pty Ltd Injectable nutritional supplement

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4335116A (en) 1980-10-07 1982-06-15 University Patents, Inc. Mineral-containing therapeutic compositions
ZA826778B (en) 1981-09-01 1983-07-27 Animalia Pty Ltd Trace elements
UY26194A1 (es) * 2000-06-06 2002-01-31 Atilio Patrone Belderrain Geor Nueva bebida canina
CA2589059C (en) 2000-08-28 2011-10-04 Warburton Technology Limited Trace elements
AT502590A1 (de) * 2001-09-27 2007-04-15 Oekopharm Forschungs Und Entwi Basenhältige mikronährstoffmischung
UY27260A1 (es) * 2002-04-11 2003-11-28 Tredin S A Bebida alimento y sanitaria para perros
US6706697B1 (en) * 2002-09-19 2004-03-16 Jason Pharmaceuticals, Inc. Diabetic nutrition and weight loss drink compositions
US20040132689A1 (en) * 2002-12-27 2004-07-08 Seiji Nishida Aqueous preparation containing a shark-derived chondroitin iron sulfate colloid
JP5702042B2 (ja) * 2004-04-09 2015-04-15 エヌ．ブイ．・ヌートリシア 濃縮液状調製物
US7285292B2 (en) 2004-04-29 2007-10-23 Warburton Technology Limited Trace elements
AU2005237315B2 (en) 2004-05-03 2009-10-08 Virbac (Australia) Pty Ltd Trace elements
US20080213395A1 (en) * 2004-10-14 2008-09-04 Adventures Plus Pty Ltd Method for the Treatment of Gastrointestinal and Other Disorders with an Admixture of Vitamins
AU2007312276B2 (en) 2006-10-19 2010-06-10 Société des Produits Nestlé S.A. Long-term enteral feed for maintenance
DE102007012644A1 (de) * 2007-03-16 2008-09-18 Bayer Healthcare Ag Stabilisierung von Vitamin B12
US20110076341A1 (en) * 2009-09-25 2011-03-31 William Alfred Smith Trace elements
US20110195158A1 (en) * 2010-02-10 2011-08-11 Fuhr David R Wildlife nutritional supplementation and methods for making the same
WO2011150395A2 (en) * 2010-05-28 2011-12-01 Bmg Hematology Llc Nutrient compositions

Also Published As

Publication number Publication date
MX2014013792A (es) 2015-05-11
EP3915569B8 (en) 2023-08-30
MX360934B (es) 2018-11-22
DK3566708T3 (da) 2021-08-23
US20150320087A1 (en) 2015-11-12
ES2883802T3 (es) 2021-12-09
HRP20211302T1 (hr) 2021-11-12
EP2849764A4 (en) 2015-12-16
EP3566708A1 (en) 2019-11-13
ZA201409093B (en) 2017-05-31
PL2849764T3 (pl) 2020-03-31
EP3566708B1 (en) 2021-07-28
PL3566708T3 (pl) 2021-11-22
ES2742812T3 (es) 2020-02-17
FI3915569T3 (fi) 2023-08-08
SI3566708T1 (sl) 2021-11-30
PT3566708T (pt) 2021-08-19
ES2953691T3 (es) 2023-11-15
EP2849764B1 (en) 2019-07-31
BR112014027576B1 (pt) 2020-06-30
EP2849764A1 (en) 2015-03-25
DK3915569T3 (da) 2023-08-21
HUE062949T2 (hu) 2023-12-28
PL3915569T3 (pl) 2023-09-18
CA2871991C (en) 2019-02-26
LT3915569T (lt) 2023-09-11
AU2012379964A1 (en) 2015-01-22
LT3566708T (lt) 2021-08-25
WO2013171538A1 (en) 2013-11-21
HUE056783T2 (hu) 2022-03-28
CA2871991A1 (en) 2013-11-21
SI3915569T1 (sl) 2023-10-30
EP4233881A2 (en) 2023-08-30
EP3915569B1 (en) 2023-07-26
PT3915569T (pt) 2023-08-17
DK2849764T3 (da) 2019-08-19
EP3915569A1 (en) 2021-12-01
US20210315997A1 (en) 2021-10-14
AU2012379964B2 (en) 2017-06-15
EP4233881A3 (en) 2023-10-04

Similar Documents

Publication Publication Date Title
NI201400078A (es) Derivados de lactamas útiles como inhibidores mutantes de idh1
ECSP14014530A (es) Compuestos inhibidores de metaloenzimas
PH12016501151A1 (en) Nrf2 regulators
CL2016001154A1 (es) Composiciones para prevenir o tratar alergias en infantes a partir de o alimentados por madres no secretoras.
CL2012002252A1 (es) Conjunto antidesgaste que incluye un elemento antidesgaste que va a montarse en un implemento o aparato que va a protegerse, un elemento de base que va a acoplarse al implemento o aparato, un elemento de bloqueo para bloquear dicho elemento antidesgaste con respecto a dicho elemento de base; base para un conjunto antidesgaste; bloqueo ; elemento de bloqueo; conjunto antidesgaste.
UY34697A (es) Métodos para preparar análogos de nucleótidos
BR112017003956A2 (pt) adsorvente para ligação de metais e produção do mesmo
BR112015023691A2 (pt) ferreamente de corte de fundo de poço, método para operar uma ferramente de corte de fundo de poço, e composição de fundo de poço".
GB201210699D0 (en) Nutritional food
MX2019010594A (es) Beta-caseina a2 y prevencion de la inflamacion del intestino.
BR112015007241A2 (pt) arranjo de pista
MX2016008128A (es) Intensificadores de aceptabilidad para alimento para mascotas, método de preparación y usos de los mismos.
MX2016000247A (es) Combinacion herbicida que comprende acidos grasos con actividad herbicida y un inhibidor de als.
CL2014003515A1 (es) Composición herbicida que tiene actividad herbicida mejorada.
MX2016000422A (es) Metodos para promover el desarrollo y/o la salud neuronal.
PH12015502665A1 (en) Improvements in or relating to organic compounds
BR112015022162A2 (pt) sonda fluorescente de zinco
CR20160083A (es) Compuestos con actividad pesticida
BR102013026779A8 (pt) ferramenta de esmerilhar
BR112015011798A2 (pt) métodos e composições para tratar doenças neurodegenerativas
BR112014027576A2 (pt) soluções de oligoelementos e de traços de elementos e métodos de preparo de soluções e de suprimento de traços de elementos
WO2014194053A3 (en) Carbohydrate compounds for nutritional and therapeutic use
MX370755B (es) Mejoradores de la palatabilidad para alimentos diseñados para perros y gatos con insuficiencia renal.
BR112019003698A2 (pt) compota de frutas contendo allulose e método para fabricar a mesma
BR112015023730A2 (pt) uso de sedoeptulose como suplemento nutricional

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B15K Others concerning applications: alteration of classification

Ipc: A61K 33/30 (2006.01), A61K 33/32 (2006.01), A61K 3

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]

Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO POR NAO SE ENQUADRAR NO ART. 229-C DA LPI.

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 14/05/2012, OBSERVADAS AS CONDICOES LEGAIS.